Nippon Shinyaku Co., Ltd. (NPPNY)
OTCMKTS · Delayed Price · Currency is USD
9.52
0.00 (0.00%)
Dec 22, 2025, 4:00 PM EST
Nippon Shinyaku Market Cap
Nippon Shinyaku has a market cap or net worth of $2.51 billion as of December 23, 2025. Its market cap has increased by 31.79% in one year.
Market Cap
2.51B
Enterprise Value
2.11B
Revenue
1.08B
Ranking
n/a
PE Ratio
11.62
Stock Price
$9.52
Market Cap Chart
Since August 18, 1993, Nippon Shinyaku's market cap has increased from 950.72M to 2.51B, an increase of 163.80%. That is a compound annual growth rate of 3.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 23, 2025 | 2.52B | 47.22% |
| Dec 30, 2024 | 1.71B | -28.36% |
| Dec 29, 2023 | 2.39B | -37.52% |
| Dec 30, 2022 | 3.82B | -18.47% |
| Dec 30, 2021 | 4.69B | 6.15% |
| Dec 30, 2020 | 4.41B | -24.67% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 820.05M |
| Glass House Brands | 755.14M |
| Elite Pharmaceuticals | 521.60M |
| Northwest Biotherapeutics | 395.14M |
| CytoDyn | 358.49M |
| Silence Therapeutics | 300.88M |
| Nika Pharmaceuticals | 291.10M |
| American Oncology Network | 190.62M |